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Background: Acinetobacter species are recognised as important nosocomial pathogens that have become a
major cause of invasive opportunistic infections in hospitalised patients. Their clinical significance is largely due
to the rapid development of antimicrobial resistance among strains. The development of antibiotic resistance
among bacterial strains occurs frequently by the acquisition of resistance genes by gene transfer systems such as
bacterial plasmids.
Method: Multi-antibiotic resistant Acinetobacter nosocomialis strain 178 was isolated from a hospital in Melbourne,
Australia. This strain was screened for the presence of plasmids. The two plasmids isolated were sequenced and
annotated.
Results: Two plasmids isolated from a single clinical Acinetobacter nosocomialis strain were sequenced. One
plasmid, designated pRAY*-v3, appears to have evolved via the same lineage as the pRAY plasmid isolated
from an Acinetobacter baumannii in South Africa. The other plasmid, designated pAB49-v1, appears to be an
evolutionary descendent from a cryptic plasmid isolated from an A. baumannii almost 20 years ago. Both of
the plasmid sequences here share a high level of sequence similarity with their ancestors, however differences
are noted.
Conclusion: The isolation of these plasmid-lineages across different decades and continents suggests their
global dissemination.
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The Acinetobacter calcoaceticus-baumannii (ACB) com-
plex [1] consists of four closely related genospecies, namely
A. calcoaceticus (genomic sp. 1), A. baumannii (genomic
sp. 2) [2], A. nosocomialis (former genomic sp. TU13) and
A. pittii (former genomic sp. 3) [3], along with two ad-
ditional unnamed genomic species [4]. These species, par-
ticularly A. baumannii, A. nosocomialis and A. pittii, are
recognised as important nosocomial pathogens that have
become a major cause of invasive opportunistic infections
among critically ill hospitalised patients [5,6]. Their clinical
significance is largely implicated by the rapid development
of multi-antimicrobial resistance among these species,
making hospital-acquired infection difficult to treat [5,6].* Correspondence: steve.petrovski18@gmail.com
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strains occurs frequently by the acquisition of resistance
genes by gene transfer systems, such as bacterial plasmids,
transposable elements and integrons, where plasmids serve
as the vehicles for resistance gene capture and their sub-
sequent dissemination throughout the microbial popula-
tion [7]. Bacterial plasmids are commonly observed among
members of the Acinetobacter genus where they are sug-
gested to play an important role in the adaptive evolution
of these organisms [7-9]. Considering this suggested role
for plasmids, coupled with their implication in serious anti-
biotic resistance issues in hospitals, makes further study
into the detail of their functions of paramount importance.
We here report the isolation and characterization of
two plasmids isolated from a single clinical strain of
A. nosocomialis obtained from a Melbourne hospital.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Gifford et al. BMC Research Notes 2014, 7:732 Page 2 of 5
http://www.biomedcentral.com/1756-0500/7/732Methods
The bacterial strain Acinetobacter sp. strain 178 was pro-
vided to us from a local Melbourne (Australia) hospital and
is the subject of this study. The source of the strain is un-
known and de-identified. The Escherichia coli K-12 deriva-
tive used for transformation of cloned DNA fragments was
DH5α (Δlac169 endA1 recA1 Res− Mod+ Nalr) [10]. The
plasmid used for cloning was pBluescript KS+. Bacteria were
grown on Luria-Bertani (LB) medium and incubated at 30 °
C for Acinetobacter strains and 37 °C for E. coli. To select E.
coli strains with conferred resistance (or A. nosocomialis
strains, as indicated) antimicrobials were added to LB at the
following final concentrations (μg mL−1): ampicillin (Ap) 50
and 100; chloramphenicol 32; tetracycline 80; kanamycin
12.5; rifampicin 2; gentamycin 10; streptomycin 10.
To determine the identity of the clinical isolate str. 178,
the 16S rRNA gene and 16S-23S Internal Transcribed Spa-
cer (ITS) region were PCR amplified using the primers 6R
(GGGTTYCCCCRTTCRGAAAT) [11] and 27 F (GAG
TTT GAT CMT GGC TCA G) [12]. Sequencing was per-
formed by Australian Genome Research Facility (AGRF)
(Brisbane, Australia) using the primers 530 F (GTG CCA
GCM GCC GCG G), 519R (GWA TTA CCG CGG CKG
CTG), 1114 F (GCA ACG AGC GCA ACC C), 907R(CCG
TCA ATT CMT TTR AGT TT) [12], 1512 F (GTCGTAA
CAAGGTAGCCGTA) and 6R (GGGTTYCCCCRTTCR
GAAAT) [11]. Phylogenetic placement was assessed with
the alignment and construction of a phylogenetic tree of
related sequences [13]. The ITS region was also sequenced
to complement 16S rRNA gene analysis, as the 16S rRNA
gene is reportedly unable to provide phylogenetic reso-
lution between species of the ACB complex [14].
Plasmids were isolated, digested with restriction endo-
nucleases HindIII and the fragments were cloned into
pBluescript KS+. The fragments were sequenced and as-
sembled, and primer walking was used to close any
remaining gaps. The fragments were sequenced using
pUC/M13 forward and reverse primers [15]. Cloning,
plasmid DNA isolation and other manipulations were
performed as described previously [16]. DNA sequence
analysis was performed using the Geneious Pro 4.0.4
and the BlastN algorithm at National Centre Biotechnol-
ogy Information (NCBI).
PCR amplification employed novel primers, BG1 (CG
ATTTATGTCAGTTCGCGG) and BG2 (CTCTGAGT
TGGCTGACAATG), to amplify a region within pAB49
and its relatives using the conditions described in
Petrovski & Stanisich, [16].
The nucleotide sequence of the 16S rRNA gene and
ITS region has been deposited in GenBank under acces-
sion number KC257034. The plasmid sequences for
pRAY*-v3 and pAB49-v1 have been deposited in GenBank
under the accession numbers KC417494 and KC417495
respectively.Results and discussion
A. nosocomialis strain 178 was selected from 41 clinical
Acinetobacter strains collected from a local Melbourne
(Australia) hospital. This strain was of particular interest
because of its relatively broad antibiotic resistance profile,
growing in the presence of gentamicin, streptomycin,
chloramphenicol and kanamycin. Gel electrophoresis
of plasmid DNA isolated from strain 178 indicated the
presence of two small plasmids ~6 kb and ~2.2 kb in
size. The plasmids were sequenced revealing they were
6,078 bp and 2,200 bp in size, correlating well with the es-
timated sizes. Both plasmids had a GC mol% content of
39%, which is similar to the genome of their host species
[17], and are here named pRAY*-v3 and pAB49-v1.
The compiled sequence of the 6,078 bp plasmid is
almost identical to the sequence of the plasmid pRAY
from Acinetobacter sp. SUN, which was isolated in the
1990s in South Africa [18]. More recently plasmids similar
to pRAY with small variations have been isolated from A.
baumannii strains in New South Wales (Australia) and
named pRAY*, pRAY*-v1 and pRAY*-v2 [19,20]. We
therefore here name this plasmid pRAY*-v3. pRAY*-v3 is
most closely related to pRAY*-v1 with only a single nu-
cleotide substitution at position 1656 from a C >G. The
other two Australian isolates pRAY* and pRAY*-v2 share
99% identity with pRAY*-v3. Comparison of pRAY*-v3
with both pRAY* and pRAY*-v2 reveals that an additional
55 to 60 bp substitution occurs within the mobA gene
(Figure 1a). pRAY*-v2 also contains an insertion of a
putative IS-element [20].
Our annotation of the pRAY*-v3 plasmid reveals five
putative ORFs designated as aadB, orf1, orf2, mobA and
mobC (Figure 1a). The aadB gene encodes an amino-
glycoside resistance protein, enabling the host to have a
competitive advantage at survival in the presence of such
antimicrobials. However, this gene is generally located
within the attI site of integrons and appears to be a gene
cassette. Despite this finding, no integrase gene is pre-
sent in pRAY*-v3 so the integration of this gene cassette
probably occurred when an integrase was provided in
trans from another DNA molecule [21]. The DNA se-
quence upstream of the aadB gene must also encode a
promoter region, as gene cassettes traditionally solely
rely on the Pc promoter, located within an integrase, for
their expression [21]. Two putative genes of unknown
function are present downstream of the aadB gene, here
named orf1 and orf2. Following these two genes are two
additional genes, mobA and mobC, thought to encode
putative mobilisation proteins. The presence of such
proteins suggests that the pRAY plasmids could be mo-
bilisable and the presence of an IS-element in pRAY*-v2
suggests that these pRAY plasmids could potentially act
as vehicles for the dissemination of transposable elements
in Acinetobacter species, particularly the ACB complex.
Figure 1 Genetic organization of isolated plasmids. (a) Genetic map of pRAY*-v3 (b) Genetic map of pAB49-v1. Arrows represent putative
open reading frames. HindIII sites are indicated on plasmid maps.
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veals most mutations have occurred within the mobA
gene, suggesting that this gene is either not essential for
plasmid replication or maintenance or that these mu-
tations have no affect on the function of the encoded
protein. This plasmid and its derivatives have been re-
portedly detected in various locations around the world
that include South Africa, Australia, Europe and the USA
[20] suggesting stable maintenance within Acinetobacter
strains. This is the first reported isolation of a pRAY li-
neage plasmid from A. nosocomialis, having previously
only been detected in A. baumannii strains, suggesting
that the pRAY-lineage plasmids are at least more widely
distributed among members of the ACB complex.
The DNA sequence of the smaller plasmid (2,200 bp),
isolated from A. nosocomialis str. 178, was compared to
other DNA sequences in GenBank and appears to be
78% similar to the first 1850 bp of the DNA sequence of
plasmid pAB49 (Acc No L77992), deposited in the data-
base in 1996 but is as yet unpublished. The remaining
350 bp of the sequence are novel. We therefore here
named this plasmid pAB49-v1.
The identification of pAB49-v1 15 years after the se-
quence submission of pAB49, without any apparent se-
lection pressure, is interesting and suggests that perhaps
these pAB49 type plasmids are stably maintained in some
Acinetobacter strains. The plasmid described here encodes
two putative genes presumably involved in plasmid repli-
cation (Figure 1b).
To determine the distribution of the plasmid among
related clinical ACB complex strains, we designed pri-
mers that would amplify a 1 kb region of its sequence
and conducted PCR on 41 Acinetobacter isolates from a
local Melbourne hospital. Only the 178 strain gave a
PCR product, indicating the presence of the pAB49-v1.
We cloned the entire pAB49-v1 into pBluescript KS +
(see materials and methods). This newly created plasmid
contained the origin of vegetation of the E. coli plasmid
pBluescript KS + and that of the A. nosocomialis plasmid
pAB49-v1. Furthermore the plasmid now had a select-
able marker, namely ampicillin. To determine its host
range we attempted to transform this plasmid into ampi-
cillin sensitive (at 50 μg/ml) Acinetobacter baumannii.
The plasmid was unable to replicate in the type strain
suggesting a narrow host range potentially restricted to
A. nosocomialis. Despite these findings, the detection of
the plasmid in two separate continents 15 years apart in-
dicates that this small plasmid may have disseminated
between Acinetobacter strains throughout the world.
Conclusion
In conclusion we isolated two plasmids from a clinical
A. nosocomialis strain from Melbourne Australia. Ances-
tors of the two plasmids have been previously isolatedand sequenced from different continents in Acinetobacter
strains. Plasmid pRAY has a selective advantage to its
host, providing a mechanism for resistance to aminoglyco-
sides, whereas pAB49 does not. The fact that such plas-
mids can be isolated many years later, in geographically
distinct locations, suggest they are strongly maintained
within their hosts, despite the smaller plasmid having
no evident selective advantage. The work presented here
suggests that these two plasmids may be widely dissemi-
nated among members of the ACB complex throughout
the world and thus could play an important role in their
ecology.
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